# Non-thyroid Malignancies With Metastases to the Thyroid Gland: A Case Series and Review of the Literature

**Authors:** Anderson Okafor, Juliana Chaves de Oliveira, Moumita S Choudhury, Julie Samantray

PMC · DOI: 10.7759/cureus.98454 · Cureus · 2025-12-04

## TL;DR

This paper presents four cases of non-thyroid cancers that later spread to the thyroid gland, highlighting the importance of accurate diagnosis and treatment.

## Contribution

The study adds new clinical insights into the rare phenomenon of thyroid metastases from non-thyroid cancers through a case series and literature review.

## Key findings

- Metastases occurred an average of 41.5 months after colorectal cancer diagnosis, 68 months after RCC, and 20.9 months after melanoma.
- Imaging features like hypoechogenicity and increased vascularity were consistent with malignancy in all cases.
- Pathology was essential for accurate diagnosis, and thyroidectomy was the primary treatment in all cases.

## Abstract

Metastasis of non-thyroid malignancies (NTMs) to the thyroid gland is an uncommon phenomenon. The most frequently reported primary tumors include renal cell carcinoma (RCC), lung cancer, colorectal cancer, breast carcinoma, and melanoma.

We present a case series of four patients with tumor-to-tumor metastases involving the thyroid gland. Primary tumors included colon adenocarcinoma, clear cell RCC, and malignant melanoma. Each case was evaluated for imaging findings and clinicopathologic features, treatment, and outcomes.

In all cases, the metastases occurred at a subsequent time following the primary cancer diagnosis. The average time to thyroid metastasis was 41.5 months for colorectal cancer, 68 months for RCC, and 20.9 months for melanoma. Imaging characteristics such as hypoechogenicity, irregular margins, increased vascularity, and fluorodeoxyglucose avidity were present and consistent with malignant features in all cases. Subsequent pathology analysis was essential for accurate diagnosis. Treatment consisted of hemi or total thyroidectomy in all cases, followed by thyroid hormone replacement therapy in three out of the four patients.

Although rare, metastases to the thyroid gland should be considered in patients with a history of malignancy who present with suspicious thyroid nodules. This case series demonstrates the diagnostic challenges and emphasizes the importance of radiologic vigilance and confirmatory histopathology in detecting and managing thyroid metastases from non-thyroid primaries.

## Linked entities

- **Diseases:** renal cell carcinoma (MONDO:0005086), lung cancer (MONDO:0005138), colorectal cancer (MONDO:0005575), breast carcinoma (MONDO:0004989), melanoma (MONDO:0005105), colon adenocarcinoma (MONDO:0002271), malignant melanoma (MONDO:0005105)

## Full-text entities

- **Diseases:** colorectal cancer (MESH:D015179), Metastases (MESH:D009362), cancer (MESH:D009369), lung cancer (MESH:D008175), thyroid nodules (MESH:D016606), RCC (MESH:D002292), colon adenocarcinoma (MESH:D003110), NTMs (MESH:D005067), malignant melanoma (MESH:D008545), breast carcinoma (MESH:D001943), Primary tumors (MESH:D001932)
- **Chemicals:** fluorodeoxyglucose (MESH:D019788)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12764360/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12764360/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12764360/full.md

---
Source: https://tomesphere.com/paper/PMC12764360